Literature DB >> 10764362

Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.

P Pouyanne1, F Haramburu, J L Imbs, B Bégaud.   

Abstract

Mesh：

Year:  2000        PMID： 10764362      PMCID： PMC27343          DOI： 10.1136/bmj.320.7241.1036

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].

Authors:  J L Imbs; P Pouyanne; F Haramburu; M Welsch; N Decker; J P Blayac; B Bégaud
Journal:  Therapie       Date:  1999 Jan-Feb       Impact factor: 2.070

2.  Drug-related hospital admissions: a review of Australian studies published 1988-1996.

Authors:  E E Roughead; A L Gilbert; J G Primrose; L N Sansom
Journal:  Med J Aust       Date:  1998-04-20       Impact factor: 7.738

3.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

Review 4.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154
  4 in total
  94 in total

Review 1.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Frequency of adverse drug reactions in children: a prospective study.

Authors:  Annie Pierre Jonville-Béra; Bruno Giraudeau; Pascal Blanc; Frèdèrique Beau-Salinas; Elisabeth Autret-Leca
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

3.  Safer medicines management in primary care.

Authors:  Anthony J Avery; Aziz Sheikh; Brian Hurwitz; Lesley Smeaton; Yen-Fu Chen; Rachel Howard; Judy Cantrill; Simon Royal
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

4.  Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals.

Authors:  V Bongard; S Ménard-Taché; H Bagheri; K Kabiri; M Lapeyre-Mestre; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

5.  Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies.

Authors:  Priya Bahri
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

6.  Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.

Authors:  Laurent Hauviller; Frédéric Eyvrard; Valérie Garnault; Vanessa Rousseau; L Molinier; Jean Louis Montastruc; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2016-02-17       Impact factor: 2.953

7.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Congruence on medication between patients and physicians involved in patient course.

Authors:  S Foss; J R Schmidt; T Andersen; J J Rasmussen; J Damsgaard; K Schaefer; L K Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

9.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

10.  Regional surveillance of emergency-department visits for outpatient adverse drug events.

Authors:  A Capuano; A Irpino; M Gallo; L Ferrante; M L Illiano; B Rinaldi; A Filippelli; F Rossi
Journal:  Eur J Clin Pharmacol       Date:  2009-03-18       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.